Background: In the present study, Tocilizumab(TCZ) was used in patients with COVID-19, who had clinical deterioration and meet the inclusion criteria, previously established by an expert panel (IL-6 >40,, Ferritine >500, PCR >10, Linfopenia <500). Methods: In a single-arm, multicenter (3 private hospital from Lima, Peru), descriptive, retrospective study adult hospitalized COVID-19 patients were included. The clinical and laboratory parameters were collected prior to the administration of TCZ and 24-48 hours after finnishing it. Data was analysed as the mean ± standard deviation for continuous variables and as an absolute value with percentages for categorical variables. The t-student test was used to compare the variables using SPSS, version 23.0. Results: A total of 20 patients (14 men, age 61.9 ± 12.7) with laboratory confirmation (PCR or serological test) for Covid-19 w...

Objective: To determine the characteristics of the place of residence and the cardiovascular risk factors in a Peruvian jungle population in July 2014. Materials and methods: A descriptive cross-sectional study conducted in individuals between 30 and 74 years old without a diagnosis of or treatment for a cardiovascular disease in an urban and rural population of the district of Yantaló. The sample was obtained using the Power Analysis and Sample Size Software (PASS) program, and consisted of 268 people (152 urban and 116 rural residents). The studied factors were hypertension (HBP), diabetes mellitus (DM), body mass index (BMI), waist-hip ratio (WHR) and smoking. Results: The urban population had higher rates of hypertension (18.4%), while the other risk factors showed no significant differences between the two populations. Conclusions: The only risk factor that showed a significant ass...